Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas
The observed therapeutic efficacy of TT supports clinical use as well as early interventions in horses. Successful use necessitates knowledge of the drug's mode of action and management of associated local site responses.
Authors
- Kerstin Bergvall (ORCID: https://orcid.org/0000-0002-9531-4613)
- Jarred Williams (ORCID: https://orcid.org/0000-0001-9873-0201)
- A. R. Hollis (ORCID: https://orcid.org/0000-0003-1954-1993)
- John M. Morton (ORCID: https://orcid.org/0000-0002-9542-1283)
- Frank Condon
- Mick Ruppin
- J. M. Ensink
- Eduard Jose‐Cunilleras (ORCID: https://orcid.org/0000-0002-4536-7717)
- Chiara Spelta
- Paul W. Reddell (ORCID: https://orcid.org/0000-0002-0993-8957)
- Y Elce (ORCID: https://orcid.org/0000-0002-0417-3190)
- Corey Saba (ORCID: https://orcid.org/0000-0003-0590-0801)
- Thomas De Ridder (ORCID: https://orcid.org/0000-0003-2628-5684)
- Raphael Labens (ORCID: https://orcid.org/0000-0002-0717-0286)
- Cassandra McGee
- Mireia Jordana‐Garcia
Institutions
- Universitat Autònoma de Barcelona (ES)
- Charles Sturt University (AU)
- University of Georgia (US)
- Utrecht University (NL)
- University of Prince Edward Island (CA)
- University of Cambridge (GB)
- Swedish University of Agricultural Sciences (SE)
Publication Details
- Journal
- Equine Veterinary Journal
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1111/evj.14502
- Citations
- 3
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Charles Sturt University
- Universiteit Utrecht
- Sveriges Lantbruksuniversitet
- Universitat Autònoma de Barcelona
- Qbiotics